Quality of Life and Its Influencing Factors in Patients with neuromyelitis optica spectrum disorder - Report - MDSpire

Quality of Life and Its Influencing Factors in Patients with neuromyelitis optica spectrum disorder

  • By

  • Lei, Zhi-Yin

  • Li, Hui-Ping

  • Yang, Qing

  • Zhang, Xiao-pei

  • Wang, Li-xin

  • Liu, Zhuyun

  • June 4, 2026

  • 0 min

Share

Factors Affecting Quality of Life in Individuals with Neuromyelitis Optica Spectrum Disorder

Overview

This study investigates the health-related quality of life (HRQoL) in Chinese patients with neuromyelitis optica spectrum disorder (NMOSD) and identifies key biopsychosocial factors influencing it. Findings indicate significant impairments in both physical and mental components of HRQoL.

Background

Neuromyelitis optica spectrum disorder (NMOSD) significantly impacts patients' quality of life. Previous studies have shown that both physical and psychological factors contribute to the overall well-being of patients with NMOSD.

Data Highlights

MeasureMedian Score
Physical Component Summary (PCS)55.5
Mental Component Summary (MCS)51.0
Role-Physical25.0
Role-Emotional33.3

Key Findings

  • Median PCS was 55.5 and MCS was 51.0.
  • Role-physical and role-emotional scores were 25.0 and 33.3, respectively.
  • Older age, depressive symptoms, social avoidance, and poor sleep quality were associated with worse PCS.
  • For MCS, depressive symptoms, social avoidance, poor sleep quality, and lower resilience were significant factors.
  • All identified associations were statistically significant (p < 0.05).

Clinical Implications

Clinicians should consider psychosocial factors such as depression, social support, and sleep quality in managing NMOSD.

Conclusion

Psychosocial factors influence HRQoL in NMOSD patients.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. Clinical Rheumatology, Assessing Quality of Life in Patients with Rheumatic Disorders
  5. MENACTRIMS NMOSD Guidelines, 2026
  6. Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder, NEJM
  7. Key Drivers of Health-Related Quality-of-Life (HRQoL) Among Patients with NMOSD, Neurology
  8. https://menactrims.org/wp-content/uploads/2026/01/MENACTRIMS-NMOSD-Guidelines.pdf
  9. Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder | New England Journal of Medicine
  10. Key Drivers of Health-Related Quality-of-Life (HRQoL) Among Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD): Findings from a Global Systematic Literature Review (SLR) (P7-8.011) | Neurology

Original Source(s)

Related Content